Global PCR Systems Market

Global PCR Systems Market

Global PCR Systems market reached US$ YY million in 2023 and is expected to reach US$ YY million by 2031, growing at a CAGR of YY% during the forecast period 2024-2031.

PCR system is used for the amplification of DNA by isolation and sequencing in the PCR systems. These are known as thermocyclers or DNA amplifiers due to the conditions with which they amplify the DNA i.e. in the presence of temperature

There are different types of PCR used for different purposes Digital PCR is a breakthrough technology with built-in settings that require limited hands on the machine. As most of the process is automatic, human intervention is very little.

Market Dynamics: Drivers & Restraints

Increasing product launches

Rising technological advancements and digitalization, PCR systems are developed in more sophisticated way with increased efficiency, durability, and portability. This has increased the launch of new products in the market by key companies. For instance, in November 2023, Roche Diagnostics launched next-generation qPCR system to improve the clinical needs in molecular diagnostics.

In January 2023, Bio-Rad Laboratories launched the CFX Opus Deepwell Dx Real-Time PCR System that is developed by European Union's Regulations. Also, in January 2024, Xi'an Tianlong Science and Technology Co., Ltd. launched its NEW Multi-block Design Real-Time PCR System, Gentier X3 Series.

False Positive Results

PCR usually amplifies the smallest fragment of DNA and hence human errors are always possible. These errors can occur due to various factors such as poor optimized amplification conditions, contamination, and improper annealing which may give false outcomes. Hence, these factors are expected to hinder the market.

Segment Analysis

The global PCR systems market is segmented based on type, application, end-user and region.

Digital PCR is Expected to Dominate the Market

Digital PCR holds the largest share in the market due to increasing technological advancements and digitalization. The launch of the products in the market increases the demand for digital PCR systems soon as key companies are mainly focusing on the development of digital PCR systems.

For instance, in August 2023, Roche Diagnostics launched the Digital LightCycler System which quantifies trace amounts of specific DNA and RNA targets in a pool of DNA and RNA. Furthermore, in March 2023, Thermo Fisher Scientific launched a New Digital PCR Automation Solution, The Applied Biosystems QuantStudio Absolute Q AutoRun dPCR Suite. It is the first digital PCR system with lab automation.

Also, in November 2023, QIAGEN launched new QIAcuity digital PCR kits with updated software, increased sensitivity, and cost efficiency to increase application in the biopharma industry.

Geographical Analysis

North America is Expected to Dominate the Global Market

North America is expected to hold the largest share in the market due to the presence of key companies like Bio-Rad Laboratories, Inc., and Thermo Fisher Scientific Inc. which are focusing on cutting-edge technology in developing more efficient and sophisticated PCR systems.

Rising chronic diseases in the US and increasing awareness about disease diagnosis among people are expected to drive the PCR systems market. Furthermore, healthcare infrastructure modernization, rising research and clinical applications, and growing knowledge among clinicians about PCR systems are a few other factors that drive the market in the forthcoming period.

Market Segmentation

By Type
• Multiplex PCR
• Long-range PCR
• Single-cell PCR
• Fast-cycling PCR
• Real Time PCR
• Digital PCR
• Methylation-specific PCR (MSP)
• High-fidelity PCR
• Hot start PCR

By Application
• Blood Testing
• Pathological Testing
• Oncology Testing
• Research and Development
• Others

By End User
• Hospitals and Clinics
• Diagnostic Centers
• Research and academic institutions
• Others

By Region
• North America
U.S.
Canada
Mexico
• Europe
Germany
UK
France
Italy
Spain
Rest of Europe
• South America
Brazil
Argentina
Rest of South America
• Asia-Pacific
China
India
Japan
Australia
Rest of Asia-Pacific
• Middle East and Africa

Key Developments
• In March 2023, Jiangsu Bioperfectus Technologies Co., Ltd. launched new Real Time PCR Kits that are independently developed by them.
• In February 2023, Thermo Fisher Scientific launched Taqpath PCR Kits in India for the detection of infectious disease such as multi drug resistant tuberculosis, hepatitis B, HIV etc.

Competitive Landscape

The major global players in the PCR systems market include Bio-Rad Laboratories, Inc, Agilent Technologies, Inc., Thermo Fisher Scientific Inc, LABGENE Scientific SA, QIAGEN, BioMérieux SA, F. Hoffmann-La Roche Ltd, Merck & Co., Inc, Fluidigm Corporation, Abbott Laboratories among others.

Why Purchase the Report?
• To visualize the global PCR systems market segmentation based on type, application, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of PCR systems market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global PCR systems market report would provide approximately 58 tables, 66 figures and 186 pages.

Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies